Lonza Group AG Logo

Lonza Group AG (LZAGY)

OTC

Currency in USD
73.27
-0.60 (-0.81%)

Real-time Data

01:30 PM

Day's Range

72.89
73.37

52 wk Range

58.53
74.00

Overview - LZAGY - Lonza Group AG

Key Statistics

Valuation

Enterprise Value

69.19B

P/E (Trailing)

‪38.07‬

P/E (Forward)

‪26.10‬

PEG Ratio

‪26.10‬

Price / Sales (TTM)

‪7.64‬

Price / Book

‪5.07‬

EV / EBITDA

‪23.11‬

Profitability

Profit Margin

‪-1.60%‬

Operating Margin

‪23.41%‬

Return on Assets

‪5.44%‬

Return on Equity

‪12.89%‬

Ownership

Shares Outstanding

69.84M

Float

697.41M

Held by Insiders

‪0.00%‬

Held by Institutions

‪0.03%‬

Price stats

Beta

‪0.83‬

50-Day Avg

‪68.55‬

200-Day Avg

‪66.34‬

Dividends

Payout Ratio

‪32.09%‬

Frequency

Annual

Analyst Consensus

Buy

3 analysts

Average price target

‪$ 83.25‬

Shariah Compliance

Not Shariah Compliant

Report Date: Feb 19, 2025

Screened by Zoya using the AAOIFI methodology.

Market Cap - LZAGY - Lonza Group AG

Peers - LZAGY - Lonza Group AG

Peer Comparison

Compared with companies in Diagnostics & Research listed on OTC.

Profile Summary - LZAGY - Lonza Group AG

About

Lonza Group AG is a Swiss multinational contract development and manufacturing organization (CDMO) serving the pharmaceutical, biotechnology, and nutrition sectors. Headquartered in Basel, Switzerland, and founded in 1897, it specializes in end-to-end solutions from early-phase discovery and custom development to…

SectorHealthcare
IndustryDiagnostics & Research
Employees20K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.